JP Morgan Chase
CDIO icon

JP Morgan Chase’s Cardio Diagnostics CDIO Stock Holding History

JP Morgan Chase’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50
Closed -$495 – 7128
2025
Q1 		$495 Buy
+50
New +$779 ﹤0.01% 6706
2023
Q4 		– Hold
0
– -$2 – 7554
2023
Q3 		– Hold
0
– – – 7404

Other funds holding CDIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase's CDIO Position: Q2 2025 in Review

JP Morgan Chase sold out of Cardio Diagnostics (CDIO) in Q2 2025, closing a stake of 50 shares — an estimated $495 sold.

JP Morgan Chase first reported a position in CDIO in Q1 2025 and held it in 1 quarter. The position peaked at $495 in Q1 2025. 16 funds tracked by Wall St. Rank hold CDIO as of Q2 2025.

  • JP Morgan Chase reported no remaining Cardio Diagnostics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 50 Cardio Diagnostics shares in Q2 2025, an estimated $495.
  • JP Morgan Chase first reported a position in Cardio Diagnostics in Q1 2025 and held it in 1 quarter.
  • JP Morgan Chase's Cardio Diagnostics position peaked at $495 in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.